Loading...

GALERA THERAPEUTICS INC Management Changes 8-K Filing

GLR

GALERA THERAPEUTICS INC

()

2026 8-K

Annual Meeting Notice

Preferred Stock Amendment

Executive Bonus Agreement

Asset Sale Agreement

Asset Sale Agreement

Royalty Agreement Update

Agreement Amendment

Acquisition Completed

Director Elections

External Links:

On February 6, 2026, Galera Therapeutics, Inc. announced a retention bonus agreement with Chief Accounting Officer Joel Sussman, allowing him to earn up to $250,000, which would reduce his severance payments if applicable.

AI Assistant

GALERA THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.